Abstract | OBJECTIVE: DESIGN: Patients received chlorthalidone 25 mg for 4 weeks, and if diastolic blood pressure remained in the range of 100-115 mm Hg, they were given titrated doses of ceronapril (10-40 mg/d based on blood pressure response) in addition to chlorthalidone for 9 weeks. SETTING: Outpatient research clinic. SUBJECTS: Eligible patients had moderate essential hypertension (diastolic blood pressure 100-115 mm Hg) assessed when the patients were receiving no medications. Thirteen patients were entered into the study; 1 withdrew for reasons unrelated to the study drug. Twelve patients (11 men, 1 woman; mean age 52 y) completed the study. INTERVENTION: MAIN OUTCOME MEASURES: CBF measurements were taken at the start and end of ceronapril therapy using intravenous 133Xe; blood pressures were determined weekly. RESULTS: Mean arterial blood pressure decreased from 130 +/- 4 to 120 +/- 7 mm Hg after 4 weeks of chlorthalidone administration, and fell further to 108 +/- 8 mm Hg after an additional 9 weeks of combined chlorthalidone- ceronapril therapy (p < 0.05). CBF fell from 44 +/- 15 to 34 +/- 5 mL/min/100 g during the 9 weeks of combined therapy (p = 0.05). No adverse effects consistent with decreased CBF were observed. The decrease in CBF was not linearly correlated with the change in systemic blood pressure, but was strongly correlated (r = -0.937; p < 0.001) with the initial CBF. CONCLUSIONS: The decrease in mean arterial blood pressure was not associated with a decrease in CBF. Patients with high CBF may be predisposed to a decrease in CBF when treated with ceronapril and chlorthalidone.
|
Authors | N R Cutler, J J Sramek, A Luna, I Mena, E P Brass, N M Kurtz, J J Brennan |
Journal | The Annals of pharmacotherapy
(Ann Pharmacother)
Vol. 30
Issue 6
Pg. 578-82
(Jun 1996)
ISSN: 1060-0280 [Print] United States |
PMID | 8792940
(Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Angiotensin-Converting Enzyme Inhibitors
- Diuretics
- Organophosphorus Compounds
- Xenon Radioisotopes
- Proline
- Chlorthalidone
- ceronapril
|
Topics |
- Aged
- Angiotensin-Converting Enzyme Inhibitors
(adverse effects, therapeutic use)
- Blood Pressure
(drug effects)
- Cerebrovascular Circulation
(drug effects)
- Chlorthalidone
(therapeutic use)
- Diuretics
(therapeutic use)
- Drug Therapy, Combination
- Female
- Homeostasis
(drug effects)
- Humans
- Hypertension
(drug therapy, physiopathology)
- Male
- Middle Aged
- Organophosphorus Compounds
(adverse effects, therapeutic use)
- Proline
(adverse effects, analogs & derivatives, therapeutic use)
- Xenon Radioisotopes
|